Prevention of Perinatal Hepatitis B Transmission.
Level 5 - mechanism / opinion, no new human data
Narrative clinical review without systematic search or primary data synthesis
PubMed 37149315 · doi:10.1016/j.ogc.2023.02.007
What was done
This narrative review summarizes standard clinical strategies and implementation recommendations for preventing perinatal transmission of hepatitis B virus (HBV) from pregnant individuals to infants.
What was found
The abstract provides no empirical data, sample sizes, or numerical effect sizes. It outlines four key clinical interventions: identifying HBsAg-positive pregnant individuals, treating HBsAg-positive pregnant individuals who have high viral loads with antivirals, administering timely postexposure prophylaxis to exposed neonates, and delivering timely universal vaccination to all newborns.
Why it matters
Perinatal transmission of HBV frequently causes chronic infection and severe liver disease. Adhering to these four established prevention steps addresses key implementation gaps in maternal and neonatal care.
Limits
The abstract describes a narrative review rather than a systematic review or empirical study, providing no quantitative outcomes, pooled effect estimates, or search criteria.
Cited by
- contradicts Hepatitis B is only transmitted via sexual contact or intravenous drug use.